Pro-inflammatory cytokine and inflammatory signaling pathways in immune cells

Pro-inflammatory cytokine and inflammatory signaling pathways in immune cells refers to the integrated biological network responsible for initiating and sustaining the immune response to harmful stimuli. This system involves a diverse array of signaling proteins, including cytokines like Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), which serve as critical intercellular communicators (StatPearls, 2023). Upon binding to their cognate receptors, these cytokines activate complex intracellular cascades such as the NF-κB, JAK-STAT, and MAPK pathways, which drive the expression of genes involved in inflammation and immune cell activation (Nature Reviews Immunology, 2018). While these pathways are vital for host defense and wound healing, their chronic or excessive activation is a primary driver of autoimmune and autoinflammatory diseases, including rheumatoid arthritis, Crohn's disease, and psoriasis (Frontiers in Immunology, 2021). Modern pharmacology targets this network through various modalities, including monoclonal antibodies that sequester cytokines and small-molecule inhibitors that target downstream kinases like JAK1 or JAK3 (PubMed, 2022). Effective management of these pathways requires balancing the suppression of pathological inflammation with the maintenance of adequate immune surveillance to prevent opportunistic infections.

Other names

Inflammatory signaling networkPro-inflammatory cytokine cascadeCytokine-mediated signaling pathwaysInflammatory signaling pathways

Therapeutic strategies involve the neutralization of pro-inflammatory cytokines, the blockade of their respective cell-surface receptors, or the inhibition of intracellular signaling enzymes such as Janus kinases (JAKs) to prevent the transcription of inflammatory genes (Nature Reviews Drug Discovery, 2022).